Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
6.96
+0.20 (2.96%)
At close: Jun 16, 2025, 4:00 PM
6.99
+0.03 (0.43%)
After-hours: Jun 16, 2025, 4:00 PM EDT

Jade Biosciences Stock Forecast

Stock Price Forecast

The 2 analysts that cover Jade Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $15.5, which forecasts a 122.7% increase in the stock price over the next year. The lowest target is $14 and the highest is $17.

Price Target: $15.5 (+122.7%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $14 $15.5 $17 $17
Change +101.15% +122.70% +144.25% +144.25%

Analyst Ratings

The average analyst rating for Jade Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '25Jun '25
Strong Buy 01
Buy 11
Hold 00
Sell 00
Strong Sell 00
Total 12

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Upgrades
$14
Strong Buy Upgrades $14 +101.15% Jun 16, 2025
Wedbush
Wedbush
Buy
Reiterates
$17
Buy Reiterates $17 +144.25% May 15, 2025
Wedbush
Wedbush
Buy
Initiates
$17
Buy Initiates $17 +144.25% May 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
10.39M
Revenue Next Year
n/a
from 10.39M
EPS This Year
-6.56
from -18.79
EPS Next Year
-31.31
from -6.56
Fiscal Year FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-10.39M-
Revenue Growth
----
EPS
-18.79-6.56-31.31-2.15
EPS Growth
----
Forward PE
----
No. Analysts
-774
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a42.8Mn/a
Avg n/a10.4Mn/a
Low n/an/an/a

Revenue Growth

Revenue Growth 202520262027
High ---
Avg ---
Low ---

EPS Forecast

EPS 202520262027
High -1.22-1.75-2.05
Avg -6.56-31.31-2.15
Low -18.52-114.56-2.22

EPS Growth

EPS Growth 202520262027
High ---
Avg ---
Low ---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.